UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2019 Financial Results
03 mars 2020 16h05 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, March 03, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology Appoints Anirvan Ghosh, Ph.D. as Chief Executive Officer
02 mars 2020 16h30 HE
|
Unity Biotechnology, Inc.
– Renowned Scientist and Drug Developer Joins UNITY’s Mission to Extend Healthspan – – Succeeds Keith Leonard Who Will Continue as Chairman – SAN FRANCISCO, March 02, 2020 (GLOBE NEWSWIRE) --...
UNITY Biotechnology Provides Pipeline and Business Updates
25 févr. 2020 06h00 HE
|
Unity Biotechnology, Inc.
– Phase 2 study of UBX0101 in patients with osteoarthritis has completed enrollment – – Topline 12- and 24-week results now expected in 2H 2020 – – First patient dosed in phase 1b study to explore...
UNITY Biotechnology, Inc. to Participate in the Cowen and Company 40th Annual Health Care Conference
24 févr. 2020 16h05 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Feb. 24, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. Announces First Patient Dosed in Phase 2 Study of UBX0101 in Osteoarthritis of the Knee
31 oct. 2019 08h00 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Oct. 31, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today...
UNITY Biotechnology, Inc. Announces Upcoming Scientific Presentations at ACR 2019 Annual Meeting
24 oct. 2019 08h00 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Oct. 24, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
Unity Biotechnology, Inc. to Announce Third Quarter 2019 Financial Results
23 oct. 2019 08h00 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Oct. 23, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY Biotechnology, Inc. to Participate in the 2019 Cantor Global Healthcare Conference
20 sept. 2019 08h00 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Sept. 20, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. to Participate in Upcoming Investor Conferences
27 août 2019 08h00 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Aug. 27, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. Reports Second Quarter 2019 Financial Results and Program Updates
07 août 2019 16h05 HE
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...